🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bipolar Disorder (BD) and Schizoaffective Disorder (SA) clients. * determi...
Status
Completed
Location
St. Joseph's Healthcare, Centre for Mountain Health Services
Start Date
2007-01
Trial ID
NCT00683709
Treatments Being Tested
The purpose of the study is to determine whether addition of sertindole to ...
Status
Completed
Location
Aalborg Psychiatric Hospital
Start Date
2006-09
Trial ID
NCT00345982
The proposed study will be conducted to compare the efficacy of maintenance...
Status
Completed
Location
Dept of Psychiatry, Aiims, Bhubaneswar
Start Date
2019-02-01
Trial ID
NCT03807882
Treatments Being Tested
Fute (Flupentixol) combined with MARTAs (Multiple-Acting Receptor Targeted ...
Status
Completed
Location
Taichung Veterans General Hospital
Start Date
2019-12-19
Trial ID
NCT04898270
Treatments Being Tested
Second-generation antipsychotics (SGAs), including clozapine, are commonly ...
Status
Completed
Location
Western Psychiatric Centre
Start Date
2010-11
Trial ID
NCT01280396
This study is designed to describe asenapine prescribing patterns in the Un...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-01
Trial ID
NCT01498770
Clozapine treatment resistant schizophrenia is still prevalent.The effectiv...
Status
Completed
Location
Department of Psychiatry.Faculty of Medicine.KhonKaen University.
Start Date
2008-06
Trial ID
NCT00753051
Treatments Being Tested
This pilot study is an eight-week, randomized, double-blind, placebo-contro...
Status
Completed
Location
Freedom Trail Clinic
Start Date
2003-09
Trial ID
NCT00573417
The goal of this research is hoping to combine traditional Chinese medicine...
Status
Unknown
Location
Taichung Veterans General Hospital
Start Date
2010-01
Trial ID
NCT01045720
Treatments Being Tested
The Optimal Treatment for Treatment-resistant Schizophrenia...
Status
Unknown
Location
DTliu
Start Date
2016-11
Trial ID
NCT02926976